default author photo

Xinxin Tan

Geneplus Beijing Institute

SCHOLARLY PAPERS

1

DOWNLOADS

23

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Dynamic Hematological Indicators Predict the Efficacy of Cdk4/6 Inhibitors in Hr-Positive, Her2-Negative Metastatic Breast Cancer: An Exploratory Analysis of the Bright-2 Trial

Number of pages: 21 Posted: 06 Aug 2025
Hangcheng Xu, Yan Wang, Qiang Sa, Yiran Zhou, Fei Ma, Pin Zhang, Ying Fan, Ruigang Cai, Qiao Li, Bo Lan, Jiani Wang, Liang Cui, Xinxin Tan, Jing Bai, Yan Hu, Xianghui Duan, Fan Yang, Jiayu Wang and Binghe Xu
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Chinese Academy of Medical Sciences - Department of Medical Oncology, Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), affiliation not provided to SSRN, Tianjin Medical University - National Clinical Research Center for Cancer, Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Geneplus Beijing Institute, Geneplus Beijing Institute, Geneplus-Beijing Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 23 (1,411,822)

Abstract:

Loading...

Metastatic Breast Cancer, HR-positive, CDK4/6 inhibitor, prognostic factor, hematological indicator